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n.s.] in predicting survival and were superior to the Child-
Pugh score (AUC: 0.677; 96% CI: 0.518–0.837).  Conclusion: 
The RI is not inferior in sensitivity and specificity to the MELD 
score. Cirrhotic patients with elevated RIs have impaired 
short- and long-term survival. The RI may help identify high-
risk patients that require special therapeutic care. 
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 Introduction 
 Advanced liver cirrhosis is associated with a poor clin-
ical outcome  [1] . Therefore, assessment of prognosis is 
important in the management of these patients. The 
Child-Pugh score has long been the most widely used 
specific scoring system in liver disease  [2, 3] . In 2002, the 
Model for End-Stage Liver Disease (MELD) was intro-
duced for patients undergoing transjugular intrahepatic 
portosystemic shunt. It is currently used to predict sur-
vival in patients awaiting liver transplantation  [3, 4] . The 
MELD seems to be superior to the Child-Pugh score in 
prioritizing potential liver recipients according to mor-
tality risk  [5] . However, it is only based on three labora-
tory variables, and thus does not take into account all 
prognostic factors that will impact on the survival of cir-
rhotic patients, notably complications due to portal hy-
pertension  [4] . There is still a need for improvement of 
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 Abstract 
 Background and Aims: Patients with advanced liver cirrho-
sis who develop renal dysfunction have a poor prognosis. 
Elevated intrarenal resistance indices (RIs) due to renal vas-
cular constriction have been described before in cirrhotic 
patients. In the current study, we prospectively investigated 
the course of intrarenal RIs and compared their prognostic 
impact with those of the Model for End-Stage Liver Disease 
(MELD) and the Child-Pugh scores.  Methods: Sixty-three pa-
tients with liver cirrhosis underwent a baseline visit which 
included a sonographic examination and laboratory tests. 
Forty-four patients were prospectively monitored. The end 
points were death or survival at the day of the follow-up vis-
it.  Results: In 28 patients, a follow-up visit was performed 
after 22  8 8 months (group 1). Sixteen patients died during 
follow-up after 12  8 8 months (group 2). Group 2 patients 
showed a significantly higher baseline RI (0.76  8 0.05) than 
group 1 patients (RI = 0.72  8 0.06; p  ! 0.05). As shown by 
receiver operating characteristic analysis, the RI and the 
MELD score achieved similar sensitivity and specificity [area 
under the curve (AUC): 0.722; 95% confidence interval (95% 
CI): 0.575–0.873 vs. AUC: 0.724; 95% CI: 0.575–0.873, z = 0.029, 
 Received: May 4, 2012
 Accepted: September 9, 2012
 Published online: November 28, 2012 
 Manuela Götzberger, MD 
 Medizinische Klinik und Poliklinik IV, Klinikum der Universität München 
 Ziemssenstrasse 1 
 DE–80336 München (Germany) 
 E-Mail manuela.goetzberger   @   med.uni-muenchen.de 
 © 2012 S. Karger AG, Basel
0012–2823/12/0864–0349$38.00/0 
 Accessible online at:
www.karger.com/dig 
 Götzberger  /Singer  /Kaiser  /Gülberg  
 
Digestion 2012;86:349–354350
prognostic markers that could be easily integrated into 
the clinical management of these patients.
 Patients with liver cirrhosis frequently develop renal 
dysfunction. The hepatorenal syndrome (HRS), the most 
serious renal complication, is associated with an ex-
tremely short survival time  [6] . The HRS is characterized 
by renal arterial vasoconstriction, which may precede 
clinically manifest renal dysfunction. The intrarenal re-
sistance index (RI) is the most frequently used parameter 
to assess intrarenal resistance and is calculated based on 
Doppler sonographic intrarenal measurements. It is rou-
tinely used to diagnose transplant rejection or renal ar-
tery stenosis  [7, 8] . Increased intrarenal RIs in patients 
with liver cirrhosis, especially in the decompensated 
stage, have been described before as compared to healthy 
controls  [9–13] . Cirrhotic patients with elevated intrare-
nal RIs tend to develop the HRS, leading to a poor prog-
nosis. In the current study, we prospectively investigated 
the course of intrarenal RIs in patients with liver cirrhosis 
and compared its prognostic impact with those of the 
MELD and the Child-Pugh scores.
 Subjects and Methods 
 Study Subjects 
 Adult patients ( 6 18 years old) with known liver cirrhosis, ad-
mitted to our outpatient clinic for surveillance of cirrhosis, were 
screened and enrolled in the study. Patients with suspected or 
overt malignant diseases, a history of insulin-dependent diabetes 
mellitus or any other nephropathy as well as patients with ongo-
ing HRS, gastrointestinal bleeding, spontaneous bacterial perito-
nitis or other acute infections at the time of the baseline visit (t 0 ) 
were excluded. A follow-up of at least 6 months was required for 
inclusion in the study. Informed consent was obtained from all 
patients before their inclusion.
 Study Design 
 At the time of the baseline visit, all patients underwent sono-
graphic examination of the liver and kidneys, including Doppler 
evaluation of intrarenal resistance.
 Patients were fasting 4 h prior to examination. For duplex 
Doppler ultrasound examination, a 3.5-MHz convex transducer 
was used (Hitachi EUB-8500 and Siemens Sonoline Elegra). So-
nographic examinations were performed by two experienced in-
vestigators, thus precluding calculation of interobserver varia-
tion. The intraobserver coefficient of variation ranged from 3.2 to 
3.4% (M.G.) and from 3.0 to 3.7% (C.K.). The RI was calculated 
with the following formula: RI = (peak systolic velocity – end di-
astolic velocity)/peak systolic velocity. Intrarenal resistance was 
measured on interlobar arteries three times in different regions of 
each kidney. Subsequently, a mean RI was calculated for each pa-
tient (mean of both kidneys).
 Laboratory tests for liver and renal function were performed 
on each patient and clinical parameters, such as blood pressure, 
heart rate and age, were measured. Hepatic encephalopathy was 
clinically assessed and classified according to the West Haven 
scale (0–4)  [14] . Ascites was graded as absent, mild to moderate or 
severe based on sonography.
 Patients were prospectively monitored. The end points were 
death or survival at the day of the follow-up visit (t 1 ). On the fol-
low-up visit, the same parameters were investigated as on the 
baseline visit (t 0 ).
 Statistical Analysis 
 All data were expressed as means  8 standard deviations. Sta-
tistical analysis was performed using SPSS. Differences between 
groups were analyzed by Student’s t test; p  ! 0.05 was considered 
significant. To discriminate the predictive value of the parame-
ters, a receiver operating characteristic (ROC) curve was estab-
lished by standard procedures  [15] . Accordingly, a z-value was cal-
culated for comparing the MELD score and the RI. Assuming a 
two-tailed probability, a z-value  1 1.96 was taken as evidence that 
ROC areas were different  [16] . Survival curves were evaluated and 
compared using the Kaplan-Meier method and the log-rank test; 
p  ! 0.05 was considered significant.
 Results 
 Seventy-one consecutive patients with liver cirrhosis 
were screened. Eight patients were excluded because of 
diabetes or other nephropathy in 6 cases and malignant 
disease in 2 cases. Sixty-three patients presented at the 
baseline visit (t 0 ), but 19 patients were lost to follow-up. 
Finally, 44 patients were enrolled in the follow-up study. 
Twenty-eight patients underwent a follow-up visit (t 1 ) af-
ter 22  8 8 months (group 1). Sixteen patients (36%) died 
after 12  8 8 months (group 2) ( fig. 1 ). Causes of death are 
16 patients died
during follow-up
(group 2)
28 patients
at t1
(group 1)
19 patients lost
to follow-up
8 patients
excluded
63 patients
at t0
71 patients
screened
 Fig. 1. Study design: 44 patients were prospectively monitored and 
divided in two groups. Patients of group 1 were also seen at t 1 . Pa-
tients of group 2 died during the follow-up. 
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shown in  table 1 and patients’ baseline characteristics of 
both groups, in  table 2 . Group 2 patients showed a base-
line RI of 0.76  8 0.05 at t 0 , which is significantly higher 
than the baseline RI of group 1 (RI = 0.72  8 0.06, p  ! 
0.05). The RI was the only documented parameter that 
differed significantly between the two groups at t 0 ( ta-
ble  3 ). In ROC analysis, the RI and the MELD score 
showed similar sensitivity and specificity [area under the 
curve (AUC): 0.722; 95% confidence interval (95% CI): 
0.575–0.873 vs. AUC: 0.724; 95% CI: 0.575–0.873, z = 
0.029, n.s.] in predicting survival and were superior to the 
Child-Pugh score (AUC: 0.677; 95% CI: 0.518–0.837) 
( fig. 2 ). According to the best accuracy derived from ROC 
analysis, we chose a cut-off of 0.74 to compare survival 
among patients (sensitivity: 62.5%; specificity: 68%).
Kaplan-Meier survival curves showed a significant dif-
ference in survival between patients with RI  1 0.74 and RI 
 ^  0.74 in the short-term as well as the long-term course 
(p = 0.037, log-rank test) ( fig. 3 ).
 On the basis of previous studies, an RI  1 0.70 was con-
sidered elevated and thus indicative of renal vasocon-
striction  [17, 18] . In group 2, only 2 patients had RIs  ! 0.70 
at t 0 . One of these patients died of sepsis due to pneumo-
nia. The cause of death of the second patient with a nor-
mal RI at t 0 is unknown. All other patients (88%) of group 
2 had RIs  6 0.72 at t 0 compared to only 50% of patients 
in group 1. Among the patients who died, the highest RIs 
(0.78  8 0.04) were found in patients with the HRS.
 In group 1, the results at t 0 and t 1 revealed a stable 
course of the liver disease. Some patients’ clinical condi-
tion even improved. At t 0 , 12 patients presented with as-
cites, but only 7 patients did so at t 1 . Consistent with the 
clinical results, patients showed a slight improvement in 
their Child-Pugh score, RI and MELD score ( table 4 ). A 
subgroup of 3 patients showed impairment in serum cre-
Table 1.  Causes of death during follow-up in group 2 patients with 
liver cirrhosis (n = 16)
Patients, n
HRS 5
Liver failure 3
Upper gastrointestinal bleeding 1
Rectum carcinoma 1
Cerebral bleeding 1
Sepsis 1
Unknown 4
Table 2.  Baseline characteristics of both groups at t0
Group 1 (n = 28) Group 2 (n = 16)
Etiology, n
Alcohol abuse 17 (60%) 12 (75%)
Chronic hepatitis B or C 7 (25%) 3 (19%)
Wilson’s disease 1 (4%) 0
Autoimmune hepatitis 1 (4%) 0
Primary biliary cirrhosis 0 1 (6%)
Cryptogenic 2 (7%) 0
Biochemical parameters
Serum bilirubin, mg/dl 2.783.0 5.8810.0
Serum albumin, g/dl 3.580.8 3.180.8
Prothrombin index, % 72817 59816
Serum creatinine, mg/dl 0.980.3 1.080.5
Clinical parameters
Ascites 12 (43%) 12 (75%)
Encephalopathy 13 (46%) 6 (37%)
Grade I 1 (4%) 4 (25%)
Grade II 12 (43%) 12 (75%)
Blood pressure, systolic 115818 117813
Blood pressure, diastolic 72813 7387
Heart rate 8288 77810
BMI 26.783.5 25.385.1
Body weight, kg 80.8811.2 74.6813.7
Portal vein flow 1685 1686
Portal vein reversal, n 4 (14%) 4 (25%)
0
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 Fig. 2.  ROC curve for the MELD score, Child-Pugh score and RI. 
The ROC curve for the MELD score and RI value showed similar 
performances. 
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atinine during the follow-up. Two patients with serum 
creatinine  1 2 mg/dl at t 1 had elevated RIs already at t 0 
(RI = 0.78 and 0.77, respectively). The patient with RI = 
0.77 at t 0 fulfilled the criteria of HRS at t 1 . The third pa-
tient demonstrated a drastically increased RI from 0.65 
to 0.79 whereas serum creatinine was only slightly in-
creased to 1.2 mg/dl at t 1 .
 Discussion 
 The current study is the first to show the similar sen-
sitivity and specificity of the intrarenal RI and the MELD 
score in assessing survival in patients with liver cirrhosis. 
Both parameters were superior to the Child-Pugh score 
in ROC analysis. In addition, we could confirm the find-
ings of previous studies showing that cirrhotic patients 
with elevated RIs have impaired short- and long-term 
survival and are at higher risk of developing the HRS. 
Kaplan-Meier survival curves demonstrated a signifi-
cantly better outcome in patients with RI  ^  0.74.
 Liver cirrhosis is characterized by complex changes in 
systemic hemodynamics. Especially renal dysfunction 
frequently complicates the clinical course of this disease. 
Doppler ultrasound measurement of intrarenal resis-
tance can estimate renal blood flow and correlates with 
portal pressure  [19] . Some studies have shown that intra-
renal RIs are significantly increased in cirrhotic patients 
compared with healthy controls and are even higher in 
patients with ascites than in patients without ascites  [9, 
10] . Patients with decompensated cirrhosis but normal 
serum creatinine can already present with elevated RIs 
 [12] . So far, two teams performed follow-up investiga-
tions of cirrhotic patients after measuring renal resis-
tance. Maroto et al.  [20]  investigated 32 cirrhotic with 
ascites. The subgroup of 17 cirrhotic patients with renal 
failure showed elevated RIs of 0.74  8 0.01. Follow-up re-
vealed the RI as an indicator of impaired survival in the 
univariate analysis. Platt et al. [18] measured intrarenal 
resistance in 180 cirrhotic patients without kidney dys-
function. During the follow-up, the HRS developed in 
26% (n = 20) of patients with an initial RI  1 0.70, but only 
in 1% of those with normal RIs. The mean initial RI in 
patients who subsequently developed the HRS was 0.77 
 8 0.05. Our findings are in agreement with previous re-
sults showing a mean RI of 0.78  8 0.04 in the 5 patients 
Table 3.  Parameters at t0 of group 1 (alive at the end of follow-up) 
and group 2 (dead at the end of follow-up)
Group 1 (n = 28) Group 2 (n = 16) p
Age, years 57810 6289 n.s.
Male/female 21/7 9/7
RI 0.7280.06 0.7680.05 <0.05
cGFR, ml/min 91.1825.0 81.2833.8 n.s.
Serum creatinine, mg/dl 0.980.3 1.080.5 n.s.
MELD score 1284 1686 n.s.
Child-Pugh score 7.782.4 9.282.0 n.s.
c GFR = Calculated glomerular filtration rate estimated ac-
cording to the Modification of Diet in Renal Disease (MDRD) 
formula.
Table 4.  Comparison of parameters in patients of group 1 at t0
and t1
Group 1 (n = 28) t0 t1 p
Age, years 57810 59810 n.s.
RI 0.7280.06 0.6980.06 <0.03
GFR, ml/min 91.1825.0 83824 n.s.
Serum creatinine, mg/dl 0.980.3 1.080.4 n.s.
MELD score 1284 1184 n.s.
Child-Pugh score 7.782.4 6.682.0 <0.02
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 Fig. 3. Kaplan-Meier survival curves according to RI demonstrat-
ed a significantly better outcome in patients with RI  ^  0.74 (p = 
0.037, log-rank test). 
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of group 2 who died due to the HRS. In the present study, 
a further RI was obtained at t 1 . The patients who were still 
alive at t 1 exhibited a stable course of their liver disease, 
possibly due to close clinical management. These results 
confirm that RIs and renal hemodynamics can improve 
with time. However, in a subgroup of 3 patients, impaired 
serum creatinine was found during the follow-up. Two 
patients with considerable worsening already had elevat-
ed RIs at t 0 , comparable to those of patients of group 1. 
This supports the assumption that an elevated RI is an 
earlier indicator of development of renal dysfunction fol-
lowed by a rise in serum creatinine with time.
 RIs  1 0.70 were defined as elevated in a number of 
studies  [17, 18] . Our data reveal that most of the high-risk 
patients had RIs  6 0.72. The optimal cut-off level for el-
evated RIs should be validated on a larger number of sub-
jects. Two patients in group 2 (12%) showed normal RIs 
at baseline, which would have led to false-negative results 
in these cases. One of these patients died due to pneumo-
nia during follow-up. The cause of death of the other pa-
tient is unknown. Apart from these aspects, other possi-
ble limitations of our results are important to consider: 
our study was designed as a single-center study and did 
not have an external validation group to further confirm 
the results.
 In conclusion, we demonstrated for the first time that 
the RI is not inferior in sensitivity and specificity to the 
MELD score. At the present time, the MELD score is 
mainly used in the transplantation setting  [5] . It is based 
on easily measured variables (prothrombin time, biliru-
bin and creatinine). Serum creatinine is an indicator of 
impaired renal function; however, it has disadvantages as 
it depends on muscle mass and physical activity. There-
fore, renal function based on serum creatinine can be 
overestimated in patients with advanced cirrhosis  [22] . 
Thus, it is still necessary to develop improved prognostic 
markers feasible in daily practice. Our study confirms 
that the RI, based on sonographic measurements of intra-
renal resistance, is an effective, noninvasive, economical 
functional test that provides useful information for the 
prognosis and management of cirrhotic patients. Elevat-
ed RIs may even disclose progress of the liver disease be-
fore changes in laboratory results. Therefore, the RI may 
help identify a subgroup of high-risk patients with a poor 
prognosis that require special therapeutic care. Accord-
ing to clinical practice guidelines, cirrhotic patients 
should be entered into surveillance programs and under-
go ultrasound examination every 6–12 months  [23] . 
Hence, our data suggest to include the measurement of 
renal resistance in these surveillance programs. 
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